You just read:

AbbVie Receives CHMP Positive Opinion for HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis

News provided by

AbbVie

Jul 21, 2017, 09:36 ET